Skip to Main Content

Browse issues

Volume 104, Issue 11, November 2019

Print and Online

Case Reports

Koen M A Dreijerink and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5421–5426, https://doi.org/10.1210/jc.2019-00202

Ten SDHD patients developed biochemically silent sympathetic paraganglioma, pheochromocytoma, or metastases. Intensified imaging may be warranted irrespective of hormonal activity in SDHD patients.

Aleida Rodriguez and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5427–5430, https://doi.org/10.1210/jc.2019-01446

Psychogenic adipsia can occur in those with mild depression.

Yu-Fang Lin and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5462–5466, https://doi.org/10.1210/jc.2019-00689

Two siblings of a Taiwanese family with GRA were found to have adrenal adenomas and somatic KCNJ5 mutation. Complete clinical cure was achieved after unilateral adrenalectomy.

Sabrina Chiloiro and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5478–5482, https://doi.org/10.1210/jc.2019-00825

Acromegaly treated with pasireotide/pegvisomant combination therapy after resistance to first- and second-line therapies is described and compared with acromegaly responsive to second-line therapies.

Venessa H M Tsang and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5499–5506, https://doi.org/10.1210/jc.2019-00423

CIADM represents a new class and increasingly common cause of autoimmune diabetes that is distinct from T1D in onset and cause; it is characterized by sudden complete β-cell failure after immune checkpoint inhibitor therapy.

Meta-Analysis

Leonie H A Broersen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5325–5337, https://doi.org/10.1210/jc.2019-01054

This systematic review shows that treatment of Cushing syndrome improves quality of life and cognitive functioning, without achieving normalization compared with healthy controls.

Asma Salari-Moghaddam and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5349–5359, https://doi.org/10.1210/jc.2019-00637

Coffee and caffeine consumption have been examined in relation to the risk of ovarian cancer. We found no significant association among caffeine intake or coffee type and the risk of ovarian cancer.

Mini-Reviews

Marie-Noel Rahhal and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 4949–4966, https://doi.org/10.1210/jc.2019-00286

In patients with advanced CKD, changes in several factors underlying insulin–glucose dynamics, in addition to decreased renal insulin clearance, necessitate detailed attention to insulin dosing.

Faraaz Ali Shah and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5274–5284, https://doi.org/10.1210/jc.2019-00296

This manuscript provides a bench-to-bedside review of the evidence supporting a potential therapeutic role for endogenous incretin hormones and exogenous incretin-derived medications in sepsis.

Angela S Kelley and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5299–5315, https://doi.org/10.1210/jc.2019-00383

In this review, we summarize current knowledge of placental dysfunction in human and animal models of PCOS and propose future directions for placental research in the population with PCOS.

Mehmet Kanbay and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5406–5420, https://doi.org/10.1210/jc.2019-01049

Recent studies show that increased serum osmolarity and high serum vasopressin levels might be novel independent risk factors for the development of hypertension and kidney and cardiovascular disease.

Gian Paolo Fadini and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5431–5444, https://doi.org/10.1210/jc.2019-00980

Angiogenesis is a fundamental biological process in health and disease. We herein review alterations of angio/vasculogenesis in diabetes and how they contribute to disease onset and complications.

Perspective

Nigel K Stepto and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5372–5381, https://doi.org/10.1210/jc.2019-00167

This perspective explores current understanding of the molecular mechanisms of PCOS-specific insulin resistance in skeletal muscle. Here, we highlight major gaps in knowledge and new opportunities.

Clinical Research Articles

Zeming Liu and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 4941–4948, https://doi.org/10.1210/jc.2018-02809

This study showed a sharply higher mortality risk of stage II thyroid cancer in patients <45/55 years old than in older patients, emphasizing the importance of age in differentiating stage II DTC.

Julie Le Mestre and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 4967–4980, https://doi.org/10.1210/jc.2019-00425

The serotonin signaling pathway is upregulated in adrenal tissues exposed to high levels of ACTH or harboring constitutive activation of the cAMP protein kinase A pathway.

Giorgio Grani and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 4981–4989, https://doi.org/10.1210/jc.2019-00962

Neck lymph node recurrences are rare in low/intermediate-risk PTCs with no evidence of disease after surgery. Subsequent sonography can be deferred if the serum Tg level is <1 ng/mL.

Subhanudh Thavaraputta and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 4990–4997, https://doi.org/10.1210/jc.2019-01132

This is a population study conducted to investigate the association between hypothyroidism and sleep apnea in the United States. A significant association between these two conditions was found.

Laura van Iersel and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 4998–5007, https://doi.org/10.1210/jc.2019-00539

In a longitudinal study, declining FT4 concentrations, suggestive for central hypothyroidism, were associated with adverse physical health outcomes in children with brain tumor after radiotherapy.

Janne Pott and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5008–5023, https://doi.org/10.1210/jc.2019-00757

Genome-wide analysis of eight steroid hormones revealed 15 novel loci involving several steroid-converting enzymes. Mendelian randomization found four steroids causally related to coronary artery disease.

Annelien C de Kat and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5024–5031, https://doi.org/10.1210/jc.2018-02607

Compared with a single AMH measurement, the use of serial AMH measurements does not improve the prediction of menopause.

Mohammad L Rahman and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5032–5042, https://doi.org/10.1210/jc.2018-02756

Maternal and offspring genetic risks of type 2 diabetes were independently and differentially associated with offspring birthweight among African ancestry populations.

Xiaojie Sun and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5043–5052, https://doi.org/10.1210/jc.2018-02492

Changes in maternal thyroid hormone were postulated to mediate the associations between metal exposure and birth outcomes. We found maternal FT3 or FT3/FT4 ratio were mediators in these associations.

Nynke Simons and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5056–5064, https://doi.org/10.1210/jc.2018-02795

Patients with aldolase B deficiency, a defect in fructose metabolism, are characterized by increased hepatic fat content and glucose intolerance compared with age-, sex-, and BMI-matched controls.

Manon Engels and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5065–5072, https://doi.org/10.1210/jc.2019-00547

Increased adrenal steroid precursors that accumulate in untreated patients with congenital adrenal hyperplasia have glucocorticoid activity in vitro.

Emily Krantz and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5073–5083, https://doi.org/10.1210/jc.2019-00340

In this 20-year follow-up study of HRQoL of women with Turner syndrome, no association between HRQoL and previous GH treatment was found, calling the relevance of GH treatment into question.

Mayuko Yamada-Harada and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5084–5090, https://doi.org/10.1210/jc.2019-00168

Composite control of modifiable risk factors, such as glucose, BP, or current smoking, was sufficient to bring CAD risk in patients with DM below that for the non-DM group who had two targets achieved.

Grace Kong and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5091–5099, https://doi.org/10.1210/jc.2019-00018

We report the incremental diagnostic value with consequent management impact of GaTate PET/CT compared with MRI or CT in follow-up of patients with SDHx pheochromocytoma/paraganglioma.

Baris Akinci and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5120–5135, https://doi.org/10.1210/jc.2018-02730

This international chart review of patients with lipodystrophy syndromes describes the disease natural history and highlights differences between generalized and partial forms.

Michael Mannstadt and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5136–5147, https://doi.org/10.1210/jc.2019-01010

Treatment of hypoparathyroidism rhPTH(1-84) for 5 years had a safety profile consistent with other studies and improved key biochemical parameters, including normalization of urinary calcium level.

Jaison Jain and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5148–5156, https://doi.org/10.1210/jc.2018-02253

A retrospective analysis of transwomen using MPA found minimal side effects, unchanged E levels, and a decline in testosterone.

Virginie Gillet and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5157–5169, https://doi.org/10.1210/jc.2018-02693
Ondřej Petrák and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5170–5180, https://doi.org/10.1210/jc.2018-02644

Predominantly pure noradrenaline, without concomitant adrenaline overproduction, has a long-term effect on the cardiovascular system in pheochromocytoma/functional paraganglioma.

Kamnesh R Pradhan and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5183–5194, https://doi.org/10.1210/jc.2019-00627

Chronic endocrine and metabolic conditions adversely affected health-related quality of life and physical activity among adult survivors of childhood cancers followed in a large North American cohort.

Emma H Dahlström and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5195–5204, https://doi.org/10.1210/jc.2019-00042
Géraldine Vitellius and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5205–5216, https://doi.org/10.1210/jc.2019-00800
Saeed Reza Toghi-Eshghi and Jane E Yardley
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5217–5224, https://doi.org/10.1210/jc.2018-02384

Morning RE performed while fasting increases blood glucose, whereas RE performed later in the day decreases blood glucose in individuals with type 1 diabetes.

Mariam Haffa and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5225–5237, https://doi.org/10.1210/jc.2019-00461
Kristine Chobanyan-Jürgens and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5238–5248, https://doi.org/10.1210/jc.2019-00411

We observed that 8 weeks of hypoxia training did not further enhance insulin sensitivity and markers of oxidative phosphorylation compared with endurance training under normoxia in older women and men.

Dirk Müller-Wieland and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5253–5262, https://doi.org/10.1210/jc.2018-02703

Alirocumab 300 mg Q4W was generally well tolerated and efficacious for improving lipid levels (e.g., LDL-C and non–HDL-C) in individuals with T2DM receiving maximally tolerated statin therapy.

Marilisa De Feudis and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5263–5273, https://doi.org/10.1210/jc.2019-00562

Proteomics and experiments in HepG2 cells showed that haptoglobin is dysregulated in GHD. GH treatment inhibits Hp secretion through mechanisms involving both GH and potentially IGF-1.

Berta Mas-Parés and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5285–5298, https://doi.org/10.1210/jc.2018-02346

We describe several umbilical cord miRNAs nominally associated with catch-up growth and identify miR-576-5p as a novel potential predictor of increased waist circumference and renal fat at 6 years.

Riccardo Pofi and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5316–5324, https://doi.org/10.1210/jc.2019-00406

After TSA, pre- and postoperative SST cortisol levels can predict 6-week HPA axis recovery. Recovery occurs even 12 months after TSA, demonstrating the need for periodic retesting.

Colleen Shelly and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5338–5348, https://doi.org/10.1210/jc.2019-00385

Prenatal and early postnatal exposures to perfluoroalkyl substances were associated with decreases in adipokine hormone levels over the childhood period in a sex-specific manner.

Frank González and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5360–5371, https://doi.org/10.1210/jc.2019-00987

We studied the effect of lipid on oxidative stress in PCOS. We found increased obesity-independent lipid-stimulated oxidative stress in PCOS that is linked to insulin resistance and hyperandrogenism.

Marina A Skiba and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5382–5392, https://doi.org/10.1210/jc.2019-01357

We have shown that the serum levels of classic and nonclassic C19-steroids decline with age and provided reference ranges for estrogens and androgens stratified by menstrual cycle stage, BMI, and age.

J Tyler Ramsey and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5393–5405, https://doi.org/10.1210/jc.2018-01880

Lavender-containing fragrances may cause premature thelarche and prepubertal gynecomastia.

Shahar Peled and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5445–5452, https://doi.org/10.1210/jc.2019-00774

We studied the association of inpatient glucose data with amputations in patients admitted for acute diabetic foot. Hypoglycemia emerged as an independent risk factor for any and major amputations.

Pamela U Freda and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5453–5461, https://doi.org/10.1210/jc.2019-01079

Plasma AgRP levels are elevated in active acromegaly and decrease with treatment with surgery or pegvisomant, providing evidence of a stimulatory effect of GH on plasma AgRP in humans.

Raquel G Martins and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5467–5477, https://doi.org/10.1210/jc.2019-01101

The metabolomic urine profile of SDHx mutation carriers with pheochromocytomas and paragangliomas is distinct from that of asymptomatic carriers and from that of their sporadic tumor counterparts.

Maria Enlund-Cerullo and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5483–5498, https://doi.org/10.1210/jc.2019-00630

In this vitamin D intervention study on 913 infants, GC genotype, diplotype, and haplotype affected vitamin D status and response to supplementation in participants randomized to receive 30 µg/d.

Commentary

Johannes Hofland and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5053–5055, https://doi.org/10.1210/jc.2019-00954

Letters to the Editor

Taher Modarressi and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5100–5101, https://doi.org/10.1210/jc.2019-00820
Stephen M Rosenthal and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5102–5103, https://doi.org/10.1210/jc.2019-00930
Johannes Hofland and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5104–5105, https://doi.org/10.1210/jc.2019-00681
Galina Smushkin and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5106–5107, https://doi.org/10.1210/jc.2019-00904
Lynn A Burmeister and Tyler Drake
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5108–5109, https://doi.org/10.1210/jc.2019-00634
Giulia Sapuppo and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5110–5111, https://doi.org/10.1210/jc.2019-00851
Zbyněk Tüdös and Filip Čtvrtlík
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5112–5113, https://doi.org/10.1210/jc.2019-00748
Letizia Canu and Henri J L M Timmers
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5114–5115, https://doi.org/10.1210/jc.2019-00868
Gianluca Tornese
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5116–5117, https://doi.org/10.1210/jc.2019-01270
Gabriela A Vasques and Alexander A L Jorge
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5118–5119, https://doi.org/10.1210/jc.2019-01428
Toshihiro Sugiyama
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5181–5182, https://doi.org/10.1210/jc.2019-01017
Fernando Bril and Kenneth Cusi
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5249–5250, https://doi.org/10.1210/jc.2019-00970
Kristina M Utzschneider and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5251–5252, https://doi.org/10.1210/jc.2019-01301

Print Abstracts—Full Content Online Only

Clinical Research Articles

Lisa Van Dyck and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5507–5518, https://doi.org/10.1210/jc.2019-00842

Withholding early parenteral nutrition to supplement insufficient enteral nutrition improves clinical outcome of critically ill patients despite further suppressing the GH axis.

Guido Di Dalmazi and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5519–5528, https://doi.org/10.1210/jc.2019-00365

Patients with incidentally discovered adrenal tumors showed different steroid profiles, depending on adrenal gland morphology, hormone secretion, and sex, with implications for blood pressure control.

Xiaoxu Huo and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5529–5539, https://doi.org/10.1210/jc.2019-00710

We found that TMAO, TMA, and its precursors were all associated with GDM. A high conversion rate to TMA and a low rate to TMAO had a synergistic effect on GDM.

Brett Barrett and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5540–5546, https://doi.org/10.1210/jc.2019-00990

This is a retrospective review of thyroid function in children and young adults treated with amiodarone. We found approximately one-third of patients developed amiodarone-induced thyroid dysfunction.

Arisa Takeuchi and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5547–5554, https://doi.org/10.1210/jc.2019-00281

The endometriosis-related reduction of ovarian reserve is at least partially caused by the excessive activation of primordial follicles, which is mediated by the PI3K-PTEN-Akt-Foxo3 pathway.

Jingjie Li and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5555–5565, https://doi.org/10.1210/jc.2019-00793

Lipid profiling alterations at the window of implantation in patients with premature P rise on the day of human chorionic gonadotrophin administration.

Silvio Buscemi and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5566–5572, https://doi.org/10.1210/jc.2019-00585

Type 1 glycogenosis is a rare disease associated with malnutrition. The measured REE was elevated in five patients and contributed to explaining the occurrence of malnutrition.

Siao Ting Chong and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5573–5584, https://doi.org/10.1210/jc.2019-00040

Our study revealed that IL13RA2 is differentially regulated in thyroid cancer and is correlated with advanced tumor stage.

Petra M Pöllänen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5585–5594, https://doi.org/10.1210/jc.2019-01069

We set out to characterize slow progression from seroconversion to overt type 1 diabetes. We found differences in autoantibodies and the season of birth, but no features specific for slow progression.

Håkan Melhus and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5595–5600, https://doi.org/10.1210/jc.2019-01063

This Mendelian randomization study found no association of genetic predisposition to higher serum parathyroid hormone concentrations with coronary artery disease.

Yu-Kwang Donovan Tay and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5601–5610, https://doi.org/10.1210/jc.2019-00893

rhPTH(1-84) therapy is safe and effective in hypoparathyroidism. Supplemental calcium and active vitamin D requirements decrease and serum calcium is maintained; renal function is stable.

Houchen Lyu and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5611–5620, https://doi.org/10.1210/jc.2019-00924

This is a head-to-head comparison study using 14 years of electronic medical records. We compared teriparatide with denosumab on BMD in patients switching from long-term bisphosphonate.

Mark Florian Joachim Weingarten and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5621–5632, https://doi.org/10.1210/jc.2019-00643

By measuring circulating oxytocin (OXT), we show that OXT is genetically determined and associated with human obesity and impaired glucose tolerance.

Seung-Hwan Lee and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5633–5641, https://doi.org/10.1210/jc.2019-01080

Low mean and high variability in HDL-C were independent predictors of diabetes, and an additive effect of these two parameters was noted.

Keisuke Nonaka and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5642–5650, https://doi.org/10.1210/jc.2019-00592

Telomere lengths in the cells from three adrenocortical zones were examined, and distinctive differences were detected among these zones in adult but not in pediatric adrenal glands.

Guido Di Dalmazi and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5651–5657, https://doi.org/10.1210/jc.2018-02209

Long-standing Cushing’s disease may lead to transition from pituitary- to adrenal-dependent hypercortisolism. In our patients, adrenal functional autonomy was caused by somatic mutations of PRKACA.

Daniel A Heinrich and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5658–5664, https://doi.org/10.1210/jc.2019-00996

We identified many cases of adrenal insufficiency after unilateral adrenalectomy for PA. We recommend performing postoperative ACTH stimulation tests in all patients undergoing this procedure.

Trevor E Angell and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5665–5672, https://doi.org/10.1210/jc.2019-00664

Association between cancer risk and clinical variable analyzed in 20,001 consecutive thyroid nodules: using patient and nodule data may provide more precise and individualized nodule risk assessment.

Cristóbal Bernardo-Castiñeira and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5673–5692, https://doi.org/10.1210/jc.2018-01471

We discovered epigenetic silencing of PCDHGC3 in metastatic SDHB-PPGLs associated with short overall disease survival and the acquisition of metastatic capabilities in tumor cells.

Yeqing Gu and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5693–5702, https://doi.org/10.1210/jc.2019-00888

The current study demonstrates that thyroid hormones significantly predict future anemia and annual changes in Hb, even in the euthyroid population.

Ole L Dollerup and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5703–5714, https://doi.org/10.1210/jc.2019-01081

Nicotinamide riboside supplementation for 12 weeks in men with obesity did not affect β-cell function or fasting or OGTT-induced concentrations of glucose, insulin, C-peptide, glucagon, GLP-1, or GIP.

Sascha Heinitz and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5715–5728, https://doi.org/10.1210/jc.2018-01980

Human, mouse, and in vitro studies suggest that ATG7 regulates chemerin secretion in adipose tissue/adipocytes. Elevated adipose autophagy in obesity may therefore manifest by elevated chemerin levels.

Rajesh K Jain and others
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 11, November 2019, Pages 5729–5736, https://doi.org/10.1210/jc.2019-00931

In a retrospective study, DM was significantly associated with the incidence of MOFs in Caucasians and Hispanics but not in African Americans.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close